Veterinary Medicines

Clavubactin 500/125 mg tablet

Authorised
  • Amoxicillin
  • Clavulanic acid
Download as PDF

Product identification

Medicine name:
Clavubactin 500/125 mg tablet
CLAVUBACTIN (500+125)MG/TAB ΔΙΣΚΙΟ
Active substance:
  • Amoxicillin
  • Clavulanic acid
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin
    500.00
    milligram(s)
    /
    1.00
    Tablet
  • Clavulanic acid
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Aluminium/aluminium strips with 4 tablets, in a cardboard box containing 25 strips.
  • Aluminium/aluminium strips with 2 tablets, in a cardboard box containing 5 strips.
  • Aluminium/aluminium strips with 10 tablets, in a cardboard box containing 25 strips.
  • Aluminium/aluminium strips with 10 tablets, in a cardboard box containing 10 strips.
  • Aluminium/aluminium strips with 10 tablets, in a cardboard box containing 1 strip
  • Cardboard box containing 10 separate cardboard boxes, each containing 5 Aluminium/aluminium strips with 2 tablets each.
  • Aluminium/aluminium strips with 4 tablets, in a cardboard box containing 50 strips.
  • Aluminium/aluminium strips with 4 tablets, in a cardboard box containing 5 strips.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • Pharmachem Consulting ApS
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 3137/16-01-2008/K-0147403
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0110/003
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • Greece
  • Lithuania
  • Luxembourg
  • Portugal
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."